We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biosimilar Interferon-Alpha Products Focus of Draft Guideline
Biosimilar Interferon-Alpha Products Focus of Draft Guideline
November 19, 2007
A new draft guideline from the European Medicines Agency describes nonclinical and clinical requirements for developing biosimilar versions of recombinant interferon-alpha products.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor